Hologic (NASDAQ:HOLX) Rating Lowered to “Neutral” at BNP Paribas Exane

Hologic (NASDAQ:HOLX) Rating Lowered to “Neutral” at BNP Paribas Exane

Hologic (NASDAQ:HOLX – Get Free Report) was downgraded by research analysts at BNP Paribas Exane from an “outperform” rating to a “neutral” rating in a research note issued on Friday, MarketBeat.com reports. They presently have a $79.00 price objective on the medical equipment provider’s stock. BNP Paribas Exane’s price target would indicate a potential upside of 6.24% from the company’s current price. Other equities analysts have also issued re…